Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Purac Planning U.S. Polymer Plant

by Alexander H. Tullo
September 20, 2010 | A version of this story appeared in Volume 88, Issue 38

Dutch lactic acid and derivatives maker Purac intends to build a $20 million plant to make resorbable lactide-based polymers for the biomedical market in the U.S. The company aims to begin construction of the plant next year. Separately, Purac and Arkema have announced a collaboration in lactide-based block copolymers. The effort will combine Arkema’s expertise in ring-opening polymerization catalysis with Purac’s L- and D-lactide monomers.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.